Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers

被引：9

作者：

Bianco A. ^{[1
]}

Valletti A. ^{[1
]}

Longo G. ^{[1
]}

Bisceglia L. ^{[2
]}

Montoya J. ^{[3
]}

Emperador S. ^{[3
]}

Guerriero S. ^{[1
]}

Petruzzella V. ^{[1
]}

机构：

[1] Dipartimento di Scienze Mediche di Base, Neuroscienze e Organi di Senso, Università Degli Studi Aldo Moro, Piazza G. Cesare, Bari

[2] Ospedale Casa Sollievo della Sofferenza IRCCS, UOC Genetica Medica, San Giovanni Rotondo

[3] Departamento de Bioquímica y Biología Molecular y Celular, Universidad de Zaragoza-CIBER de Enfermedades Raras (CIBERER), Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza

来源：

BMC Research Notes | / 11卷 / 1期

关键词：

Incomplete penetrance; Leber's hereditary optic neuropathy; Mitochondrial genome; mtDNA copy number;

D O I：

10.1186/s13104-018-4025-y

中图分类号：

学科分类号：

摘要：

Objectives: Leber's hereditary optic neuropathy (LHON) is a mitochondrial genetic disease characterized by a variable and reduced penetrance. Individuals carrying a primary LHON-causing mitochondrial DNA (mtDNA) mutation may either remain asymptomatic lifelong, as unaffected carriers, or develop sudden central visual loss that rapidly aggravates over some weeks. Over the years several genetic/environmental triggers able to modulate the risk of developing LHON have been proposed. We provided data supporting a possible correlation between LHON penetrance and the mtDNA copy number, a raw index of mitochondrial mass, whose increase could represent a compensatory response that cells implement to alleviate the pathogenic effect of the primary LHON-causing mtDNA mutations. Data description: We collected Italian and Spanish subjects harboring one of the three common LHON primary mutations, either in heteroplasmic or homoplasmic status. For each population we were able to discriminate between affected subjects presenting typical clinical tracts of LHON and LHON-causing mutation carriers showing no symptoms correlated with vision loss. Each subject has been characterized for the presence of a LHON primary mutation, for its status of homoplasmy or heteroplasmy, and for the mtDNA content per cell, expressed as relative mtDNA/nDNA ratio respect to controls. Additional clinical information is present for all the Italian subjects. © 2018 The Author(s).

引用

共 21 条

[1]

Bi R., Zhang A.M., Yu D., Chen D., Yao Y.G., Screening the three LHON primary mutations in the general Chinese population by using an optimized multiplex allele-specific PCR, Clin Chim Acta, 411, 21-22, pp. 1671-1674, (2010)

[2]

Carelli V., Rugolo M., Sgarbi G., Ghelli A., Zanna C., Baracca A., Et al., Bioenergetics shapes cellular death pathways in Leber's hereditary optic neuropathy: A model of mitochondrial neurodegeneration, Biochim Biophys Acta, 1658, 1-2, pp. 172-179, (2004)

[3]

Dimitriadis K., Leonhardt M., Yu-Wai-Man P., Kirkman M.A., Korsten A., De Coo I.F., Et al., Leber's hereditary optic neuropathy with late disease onset: Clinical and molecular characteristics of 20 patients, Orphanet J Rare Dis, 9, (2014)

[4]

Howell N., Mackey D.A., Low-penetrance branches in matrilineal pedigrees with Leber hereditary optic neuropathy, Am J Hum Genet, 63, 4, pp. 1220-1224, (1998)

[5]

Carelli V., Ross-Cisneros F.N., Sadun A.A., Mitochondrial dysfunction as a cause of optic neuropathies, Prog Retin Eye Res, 23, 1, pp. 53-89, (2004)

[6]

Yu-Wai-Man P., Griffiths P.G., Chinnery P.F., Mitochondrial optic neuropathies - Disease mechanisms and therapeutic strategies, Prog Retin Eye Res, 30, 2, pp. 81-114, (2011)

[7]

Bentlage H.A., Attardi G., Relationship of genotype to phenotype in fibroblast-derived transmitochondrial cell lines carrying the 3243 mutation associated with the MELAS encephalomyopathy: Shift towards mutant genotype and role of mtDNA copy number, Hum Mol Genet, 5, 2, pp. 197-205, (1996)

[8]

Toompuu M., Tiranti V., Zeviani M., Jacobs H.T., Molecular phenotype of the np 7472 deafness-associated mitochondrial mutation in osteosarcoma cell cybrids, Hum Mol Genet, 8, 12, pp. 2275-2283, (1999)

[9]

Wredenberg A., Wibom R., Wilhelmsson H., Graff C., Wiener H.H., Burden S.J., Et al., Increased mitochondrial mass in mitochondrial myopathy mice, Proc Natl Acad Sci USA, 99, 23, pp. 15066-15071, (2002)

[10]

Dimauro S., Schon E.A., Carelli V., Hirano M., The clinical maze of mitochondrial neurology, Nat Rev Neurol, 9, pp. 429-444, (2013)

← 1 2 3 →